MLM
ARMP icon

Mount Lucas Management’s Armata Pharmaceuticals ARMP Stock Holding History

Mount Lucas Management’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-52
Closed -$11K – 159
2016
Q2 		$11K Buy
52
+33
+174% +$11.4K ﹤0.01% 143
2016
Q1 		$11K Buy
+19
New +$9.74K ﹤0.01% 122

Other funds holding ARMP

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mount Lucas Management's ARMP Position: Q3 2016 in Review

Mount Lucas Management sold out of Armata Pharmaceuticals (ARMP) in Q3 2016, closing a stake of 52 shares — an estimated $11K sold.

Mount Lucas Management first reported a position in ARMP in Q1 2016 and held it in 2 quarters. The position peaked at $11K in Q2 2016. 15 funds tracked by Wall St. Rank hold ARMP as of Q3 2016.

  • Mount Lucas Management reported no remaining Armata Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Mount Lucas Management sold 52 Armata Pharmaceuticals shares in Q3 2016, an estimated $11K.
  • Mount Lucas Management first reported a position in Armata Pharmaceuticals in Q1 2016 and held it in 2 quarters.
  • Mount Lucas Management's Armata Pharmaceuticals position peaked at $11K in Q2 2016.
  • 15 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q3 2016.

Based on Mount Lucas Management's 13F filing for Q3 2016, filed 14 Nov 2016.